| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |